| Marine glycosyl hydrolases in the hydrolysis and synthesis of oligosaccharides A Giordano, G Andreotti, A Tramice, A Trincone Biotechnology Journal: Healthcare Nutrition Technology 1 (5), 511-530, 2006 | 111 | 2006 |
| Pharmacological chaperones: a therapeutic approach for diseases caused by destabilizing missense mutations L Liguori, M Monticelli, M Allocca, B Hay Mele, J Lukas, MV Cubellis, ... International journal of molecular sciences 21 (2), 489, 2020 | 102 | 2020 |
| CDG therapies: from bench to bedside S Brasil, C Pascoal, R Francisco, D Marques-da-Silva, G Andreotti, ... International journal of molecular sciences 19 (5), 1304, 2018 | 94 | 2018 |
| Structural determinants of salmon calcitonin bioactivity: the role of the Leu-based amphipathic α-helix G Andreotti, BL Méndez, P Amodeo, MAC Morelli, H Nakamuta, A Motta Journal of biological chemistry 281 (34), 24193-24203, 2006 | 75 | 2006 |
| Solution structure of human calcitonin in membrane‐mimetic environment: The role of the amphipathic helix A Motta, G Andreotti, P Amodeo, G Strazzullo, MAC Morelli Proteins: Structure, Function, and Bioinformatics 32 (3), 314-323, 1998 | 74 | 1998 |
| A folding-dependent mechanism of antimicrobial peptide resistance to degradation unveiled by solution structure of distinctin D Raimondo, G Andreotti, N Saint, P Amodeo, G Renzone, ... Proceedings of the National Academy of Sciences 102 (18), 6309-6314, 2005 | 73 | 2005 |
| Looking for protein stabilizing drugs with thermal shift assay G Andreotti, M Monticelli, MV Cubellis Drug testing and analysis 7 (9), 831-834, 2015 | 57 | 2015 |
| An extremely thermostable aromatic aminotransferase from the hyperthermophilic archaeon Pyrococcus furiosus G Andreotti, MV Cubellis, G Nitti, G Sannia, X Mai, MWW Adams, ... Biochimica et Biophysica Acta (BBA)-Protein Structure and Molecular …, 1995 | 54 | 1995 |
| 13C NMR spectra of TAG: An easy way to distinguish milks from different animal species G Andreotti, R Lamanna, E Trivellone, A Motta Journal of the American Oil Chemists' Society 79 (2), 123-127, 2002 | 53 | 2002 |
| Prediction of the responsiveness to pharmacological chaperones: lysosomal human alpha-galactosidase, a case of study G Andreotti, MR Guarracino, M Cammisa, A Correra, MV Cubellis Orphanet journal of rare diseases 5, 1-11, 2010 | 52 | 2010 |
| Characterization of aromatic aminotransferases from the hyperthermophilic archaeon Thermococcus litoralis G Andreotti, MV Cubellis, G Nitti, G Sannia, X Mai, G Marino, ... European journal of biochemistry 220 (2), 543-549, 1994 | 51 | 1994 |
| Protective Role of a TMPRSS2 Variant on Severe COVID-19 Outcome in Young Males and Elderly Women M Monticelli, B Hay Mele, E Benetti, C Fallerini, M Baldassarri, S Furini, ... Genes 12 (4), 596, 2021 | 50 | 2021 |
| The preferred conformation of the tripeptide Ala-Phe-Ala in water is an inverse γ-turn: Implications for protein folding and drug design A Motta, M Reches, L Pappalardo, G Andreotti, E Gazit Biochemistry 44 (43), 14170-14178, 2005 | 49 | 2005 |
| Characterization of buffalo milk by 31P-nuclear magnetic resonance spectroscopy G Andreotti, E Trivellone, A Motta Journal of Food Composition and Analysis 19 (8), 843-849, 2006 | 43 | 2006 |
| The large phenotypic spectrum of Fabry disease requires graduated diagnosis and personalized therapy: A meta-analysis can help to differentiate missense mutations V Citro, M Cammisa, L Liguori, C Cimmaruta, J Lukas, MV Cubellis, ... International Journal of Molecular Sciences 17 (12), 2010, 2016 | 41 | 2016 |
| Conformational response to ligand binding in phosphomannomutase2: Insights into inborn glycosylation disorder G Andreotti, IC de Vaca, A Poziello, MC Monti, V Guallar, MV Cubellis Journal of Biological Chemistry 289 (50), 34900-34910, 2014 | 40 | 2014 |
| Hydrolyses and transglycosylations performed by purified α-D-glucosidase of the marine mollusc Aplysia fasciata G Andreotti, A Giordano, A Tramice, E Mollo, A Trincone Journal of biotechnology 122 (2), 274-284, 2006 | 40 | 2006 |
| Therapy of Fabry disease with pharmacological chaperones: from in silico predictions to in vitro tests G Andreotti, V Citro, A De Crescenzo, P Orlando, M Cammisa, A Correra, ... Orphanet journal of rare diseases 6, 1-10, 2011 | 39 | 2011 |
| β-Glucose-1, 6-bisphosphate stabilizes pathological phophomannomutase2 mutants in vitro and represents a lead compound to develop pharmacological chaperones for the most common … M Monticelli, L Liguori, M Allocca, G Andreotti, MV Cubellis International Journal of Molecular Sciences 20 (17), 4164, 2019 | 38 | 2019 |
| Converting the highly amyloidogenic human calcitonin into a powerful fibril inhibitor by three-dimensional structure homology with a non-amyloidogenic analogue G Andreotti, RM Vitale, C Avidan-Shpalter, P Amodeo, E Gazit, A Motta Journal of biological chemistry 286 (4), 2707-2718, 2011 | 37 | 2011 |
